SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1094J.M. Dutton&Associates Announces Investment Opinion: Neurobiological Technolmopgcw-10/4/2002
1093RICHMOND, Calif., Sept. 27 /PRNewswire-FirstCall/ -- Neurobiological Technologienigel bates-9/27/2002
1092Reuters Market News Forest withdraws filing for Alzheimer's drug Monday Sepkeokalani'nui-9/23/2002
1091Memantine Investor Information Message 18020069 John McCarthyJohn McCarthy-9/21/2002
1090EW YORK, Sept. 10 /PRNewswire-FirstCall/ -- Forest Laboratories Inc., (NYSE: FRXnigel bates-9/10/2002
10892002 - [NTII][TaglichBrothers Forecast 6/18/2002] We are projecting that in 2004John McCarthy-8/18/2002
1088Neurobiological/Payment -2: Can Fully Fund Business Plan 08-12-02 03:04 PM Emopgcw-8/12/2002
10872002 - [Memantine - 5 Minute Review] Message 17832064 John McCarthyJohn McCarthy-8/3/2002
10862002 - [Memantine][BBB and AEA] Modulation of Blood-Brain Barrier Dysfunction aJohn McCarthy-8/3/2002
10852002 - [Memantine NDA][Speculation about 4 outcomes] by Leon Henderson, M.D. BeJohn McCarthy-8/3/2002
10842002 - [Memantine][Antidepressant Trial][NIMH] An Investigation of the AntideprJohn McCarthy-8/1/2002
10832002 - [Memantine NDA Filing][NTII Press Release] Thursday August 1, 12:35 pm EJohn McCarthy-8/1/2002
10822002 - [NTII Stock Buyback][500,000 shares] Thursday August 1, 12:17 pm EasternJohn McCarthy-8/1/2002
10812002 - [Memantine][8th International AD Conference] Yahoo .... jingle - nice fJohn McCarthy-7/14/2002
10802002 - [Memantine][London New Drugs Group][May] Page 1 London New Drugs Group AJohn McCarthy-7/14/2002
10792002 - [Wall Stree Transcript] PAUL FREIMAN - NEUROBIOLOGICAL TECHNOLOGIES INC John McCarthy-7/9/2002
10782002 - [Ebixa to be valued at over $820 million by 2009.] Alzheimer’s treatmentJohn McCarthy-6/30/2002
1077[2002] [Market Size] [AD Europe] alzheimer-europe.org Menu:Prevalence in EuropJohn McCarthy-5/23/2002
1076authorisation for Ebixa® H. Lundbeck A/S Printable version NEWS RELEASE 0John McCarthy-5/23/2002
10752002 - [Dextromethorphan and memantine in painful diabetic neuropathy and postheJohn McCarthy-5/1/2002
10742002 - [Revised Taglitch Report 3/5/2002] e.p.s. - fully diluted - fiscal year John McCarthy-3/9/2002
1073george - we are looking at a $1 billion dollar cash inflow ... in the next 10 yJohn McCarthy-3/3/2002
1072>NTII’s modus operandi of in-licensing promising compounds >and of pursuinmopgcw-3/3/2002
1071Our EPS estimates of $0.03 for fiscal 2002 and $2.13 for fiscal 2003 are based John McCarthy-3/3/2002
10702002 - [Data on Forest Laboratories' Investigational Alzheimer's DiseaseJohn McCarthy-2/26/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News